image

The best stocks to buy since 1993

Latest issue now available

Horizon Discovery - Growing sales like topsy

February 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • HZD
  • Price:
  • 223p
Small biotechnology investments are looking more favourable and there have been several new issues in the past year. One that is hugely exciting is Horizon Discovery, a business which isn’t developing therapies but provides enabling tools and services to companies developing personalised medicine (individualized drugs based on genetic variation).The company is growing sales like topsy and we made the shares a 2015 NAP last month. In 2013 Horizon was in Deloitte’s list of the UK’s fastest growing companies when sales were £6.6m and since our write up last month, Horizon has said sales in FY14  jumped to “at least £11.8m.” Like many companies of this type, the things Horizon is doing are ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe